ARTG Entry
GLENMARK
ARTG entry for GLENMARK (mometasone furoate), ARTG 317547 — Product Information, dosage form, registration history. Compiled by arcimedes.
- Sponsor: Glenmark Pharmaceuticals
- Active ingredient: mometasone furoate
- Therapeutic area: Dermatology
I appreciate your detailed request, but
I need to clarify an issue with the source documents provided.
The documents you have supplied describe **NASONEX Aqueous Nasal Spray 0.05%** (mometasone furoate nasal spray for allergic rhinitis, nasal polyps, and acute rhinosinusitis) and **GLENMARK MOMETASONE** products (ointment and cream formulations for dermatological use).
However, these are **different medicines** with different indications, formulations, and clinical profiles. NASONEX is not a GLENMARK brand product—it is sponsored by Organon Pharma Pty Ltd. The GLENMARK products listed in the ARTG are topical dermatological formulations (ointment and cream), not nasal sprays.
To write an accurate Brand Dossier, I would need source documents that specifically cover the GLENMARK mometasone products (the 1 mg/g ointment and/or 1 mg/g cream) registered under ARTG 266268 and 317547, including their approved indications, dosing, safety information, and regulatory history.
The NASONEX information provided would be suitable for a dossier on that brand, but would not be appropriate for GLENMARK products.
Could you please confirm: 1. Which GLENMARK product(s) you would like documented (the ointment, the cream, or both)? 2. Whether you have source documents (such as product information sheets or regulatory documents) for those specific formulations?